ABSTRACT
BACKGROUND Health-care workers (HCWs) could be at increased occupational risk for SARS-CoV-2 infection due to increased exposure. Information regarding the burden of COVID-19 epidemic in HCWs living in Mexico is scarce. Here, we aimed to explore the epidemiology, symptoms, and risk factors associated with adverse outcomes in HCWs in Mexico City.
METHODS We explored data collected by the National Epidemiological Surveillance System in Mexico City, in HCWs who underwent real-time RT-PCR test. We explored COVID-19 outcomes in HCWs and the performance of symptoms to detect SARS-CoV-2 infection.
RESULTS As of September 20th, 2020, 57,758 HCWs were tested for SARS-CoV-2 and 17,531 were confirmed (30.35%); 6,610 were nurses (37.70%), 4,910 physicians (28.0%), 267 dentists (1.52%) and 5,744 laboratory personnel and other HCWs (32.76%). Overall, 2,378 HCWs required hospitalization (4.12%), 2,648 developed severe COVID-19 (4.58%), and 336 required mechanical-ventilatory support (0.58%). Lethality was recorded in 472 (0.82%) cases. We identified 635 asymptomatic SARS-CoV-2 infections (3.62%). Compared with general population, HCWs had higher incidence, testing, asymptomatic and mortality rates. No individual symptom offers adequate performance to detect SARS-CoV2. Older HCWs with chronic non-communicable diseases and severe respiratory symptoms were associated with higher risk for adverse outcome; physicians were at higher risk compared with nurses and other HCWs.
CONCLUSIONS We report a high prevalence of SARS-CoV-2 infection in HCWs in Mexico City. Symptoms as a screening method is not efficient to discern those HCWs with a positive PCR-RT test. Particular attention should focus on HCWs with risk factors to prevent adverse outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data were obtained from a city-based epidemiological study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We updated the manuscript and included population-based analyses relating to HCWs
Data Availability
All data sources and R code are available for reproducibility of results at https://github.com/oyaxbell/covid_hcws_mx.
